Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 12/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7159943 | 0.84 | ACHE (0.65) | ACHE | |
| SCHEMBL7573517 | 0.84 | CHRNB2 (0.40) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL7152429 | 0.83 | CHRNB2 (0.43) | CHRNB2CHRNA4ACHEALDH1A1SMN1; SMN2 | |
| SCHEMBL16674069 | 0.78 | ACHE (0.60) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL5174474 | 0.76 | ALDH1A1 (0.56) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL15082337 | 0.74 | ALDH1A1 (0.54) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL16298774 | 0.74 | ACHE (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL16298775 | 0.74 | ACHE (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL21878513 | 0.73 | CHRNB2 (0.47) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE | |
| SCHEMBL5247780 | 0.73 | ACHE (0.52) | CHRNB2CHRNB4CHRNA3CHRNA4ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4176721-B1 | BIOCIDAL POLYMER BLENDS | LANXESS DEUTSCHLAND GMBH (DE) | 2026-01-07 | — | — | EP | claimed |
| US-20240215572-A1 | ANTIMICROBIAL PARTICLE DISPERSION | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2024-07-04 | — | — | US | claimed |
| EP-2413697-B1 | STABILISATION OF COMPOUNDS CONTAINING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-08 | — | — | EP | claimed |
| US-20170215421-A1 | BIOCIDE AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-03 | — | — | US | claimed |
| EP-2779830-B1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2017-05-17 | — | — | EP | claimed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | claimed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | claimed |
| US-9296878-B2 | Fungicide formulations for plasticized PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2016-03-29 | — | — | US | claimed |
| EP-2831161-B1 | FUNGICIDE FORMULATIONS FOR PLASTICIZED PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2015-11-18 | — | — | EP | claimed |
| US-8921451-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-20140303277-A1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2014-10-09 | — | — | US | claimed |
| EP-1981629-B1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2013-10-16 | — | — | EP | claimed |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2012-12-06 | — | — | US | claimed |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2012-08-16 | — | — | US | claimed |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-26 | — | — | US | claimed |
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-12 | — | — | US | claimed |
| US-7943644-B2 | Stabilization of iodine-containing biocides by means of special azole compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2011-05-17 | — | — | US | claimed |
| US-20110009268-A1 | IPBC-CONTAINING COACERVATES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-13 | — | — | US | claimed |
| US-4474807-A | 2-(3-Iodo-2-propynyloxy)-ethyl carbamates, the preparation thereof, and their use as antimicrobial agents | HENKEL KOMMANDIGESELLSCHAFT AUF AKTIEN (DE) | 1984-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178804-A1 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS | SLCO4C1, SLCO2B1, SLCO2A1 | CHRNB2 3083/4885CHRNB4 2828/4885CHRNA3 3720/4885 |
| US-20140303277-A1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | NISCH, INMT, TPO | CHRNB2 4451/4885CHRNB4 4461/4885CHRNA3 4713/4885 |
| US-20240215572-A1 | ANTIMICROBIAL PARTICLE DISPERSION | Q6ZSR9, PAM, ACMSD | CHRNB2 4843/4885CHRNB4 4862/4885CHRNA3 4799/4885 |
| US-20120186487-A1 | INORGANIC CARRIER MATERIALS CONTAINING HETEROCYCLIC 3-RING COMPOUNDS | SLCO4C1, SLCO1B3, ABCC3 | CHRNB2 2335/4885CHRNB4 1846/4885CHRNA3 1079/4885 |
| US-20120309897-A1 | Polymers containing heterocyclic 3-ring compounds and iodine-containing compounds | TPO, BRD4, SSTR3 | CHRNB2 4586/4885CHRNB4 4445/4885CHRNA3 3524/4885 |
| US-20120208918-A1 | STABILIZATION OF COMPOUNDS COMPRISING IODINE | TPO, AZI2, NISCH | CHRNB2 4543/4885CHRNB4 4664/4885CHRNA3 4812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.